144,659 members

Skip to content. | Skip to navigation

News

NICE approves new type of treatment for Crohn’s disease

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NICE approves new type of treatment for Crohn’s disease

Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.

Ustekinumab (also called Stelara, manufactured by Janssen) will be available for patients with moderate to severe Crohn’s disease.

It is recommended by NICE as an option for treating the disease in adults who have had little or no response, or an intolerance to existing therapies.

Crohn’s disease is an inflammatory bowel disease, and can affect any part of the digestive system. Symptoms can include stomach cramps, diarrhoea and fatigue. It is a chronic condition which means that is it lifelong.